Health Strategies Group Key Finding #1 12/3/2018 Health Strategies Group Commercial Plans Prioritize Cost Reduction; However, Clinical Goals Remain Critical Biopharmaceutical companies can leverage the importance commercial plans place on clinical goals by offering compelling, clinically differentiating value propositions for products in order to direct plans to shift their focus beyond unit product costs to total disease/care management costs. Ideally, our primary goal is obviously the right medicine for the patient, that's our ultimate goal. We also have to ensure value, making sure that drug A is the right medicine versus B. Ideally, drug A would be less expensive than B, but that’s not always true. – Senior Medical Director, Blues Plan To request slides info@healthstrategies.com